News for 'Sun Pharmaceuticals'

Indian Start-up Serendipity Space Achieves Drug Crystallisation In Near-Space

Indian Start-up Serendipity Space Achieves Drug Crystallisation In Near-Space

Rediff.com14 Aug 2026

Odisha-based Serendipity Space successfully demonstrated drug crystallisation processes on a satellite prototype in a near-space mission. This breakthrough aims to enable pharmaceutical manufacturing in low Earth orbit, leveraging microgravity to create superior drug crystal structures for enhanced solubility, stability, and effectiveness. The mission tested core technologies, including an autonomous pharmaceutical factory, and was inspired by advancements made on the International Space Station.

'Sword to kill mosquito': HC raps Maha FDA over Cadila drug action

'Sword to kill mosquito': HC raps Maha FDA over Cadila drug action

Rediff.com11 Aug 2026

The Bombay High Court has strongly criticised the Maharashtra FDA for its "shoot first" approach, likening its drastic actions to using a sword to kill a mosquito. The court, hearing a petition from Cadila Pharmaceuticals, directed the FDA to grant companies a hearing before taking severe measures, warning of heavy costs for its arbitrary conduct.

Indian drugmakers in no rush to shift to US despite tariff threat

Indian drugmakers in no rush to shift to US despite tariff threat

Rediff.com10 Aug 2026

Indian pharmaceutical companies are not rushing to relocate manufacturing to the United States despite former President Donald Trump's renewed threat of tariffs up to 200 per cent on imported generic drugs. Instead, they are leveraging existing US plants, contract manufacturers, and making selective investments in complex products while maintaining India as their primary production hub.

India sees Rs 4,896 crore FDI in 29 projects after easing China stake norms

India sees Rs 4,896 crore FDI in 29 projects after easing China stake norms

Rediff.com3 days ago

India has attracted foreign direct investment (FDI) worth approximately 4,896 crore across 29 projects since May, following the government's relaxation of norms under Press Note 2 of 2026. The revised rules permit investment without government approval from entities with up to 10 per cent non-controlling ownership by land-bordering countries.

Putin Offers More Fertilisers To India

Putin Offers More Fertilisers To India

Rediff.com6 hours ago

Russia remains India's biggest fertiliser supplier, with imports rising nearly 40 per cent in 2025.

Sun Pharma sees 27% profit surge in Q1FY27, driven by India and innovative medicines

Sun Pharma sees 27% profit surge in Q1FY27, driven by India and innovative medicines

Rediff.com1 Aug 2026

Sun Pharmaceutical Industries reported a 27 per cent year-on-year increase in consolidated net profit to 2,894.7 crore for Q1FY27, with revenue growing 10 per cent to 15,299.8 crore, driven by strong performance in India and innovative medicines.

0%, 100%, 200%: Trump's new generic drug tariff may hit India

0%, 100%, 200%: Trump's new generic drug tariff may hit India

Rediff.com22 Jul 2026

US President Donald Trump announced steep tariffs on imported generic medicines, effective from August 2028, with the aim of boosting domestic pharmaceutical production. This policy, which includes a phased increase in tariffs up to 200 per cent, could significantly impact India, a major global supplier of generic drugs to the US market.

11-year-old rape survivor delivers baby girl in Haryana hospital

11-year-old rape survivor delivers baby girl in Haryana hospital

Rediff.com29 Jul 2026

An 11-year-old rape survivor in Yamunanagar, Haryana, has given birth to a baby girl at the District Civil Hospital. Both the mother and baby are in stable condition. The minor's pregnancy was discovered in May, leading to the arrest of the accused under the POCSO Act. The family has consented to hand over the newborn to the Child Welfare Committee.

MutAIverse: AI Breakthrough In Decoding Cancer's Origins

MutAIverse: AI Breakthrough In Decoding Cancer's Origins

Rediff.com5 days ago

Researchers at Delhi's Indraprastha Institute of Information Technology have developed 'MutAIverse', a generative AI platform designed to decode DNA damage and identify potential causes of cancer. Tested on head and neck cancer patients in Guwahati, the platform successfully traced exposure to smokeless tobacco as a contributing factor. This innovation aims to shift focus from just diagnosis to understanding causative factors, potentially aiding in prevention and protection.

Alzheimer's Can't Be Cured, But Delayed

Alzheimer's Can't Be Cured, But Delayed

Rediff.com4 days ago

'Think of the brain like a machine, and Alzheimer's is like rust.'
'Like a rusty machine breaks down, a rusty brain also breaks down. And when it breaks down, you have memory loss, cognitive issues and so on.'

Sensex, Nifty tank nearly 1% as crude oil prices surge and bank stocks face selling pressure

Sensex, Nifty tank nearly 1% as crude oil prices surge and bank stocks face selling pressure

Rediff.com22 Jul 2026

Indian benchmark indices Sensex and Nifty tumbled nearly 1 per cent for the third consecutive day, driven by a sharp spike in crude oil prices and significant selling in bank stocks, with Brent crude jumping to USD 95.27 per barrel.

Parliamentary Panel Pushes for Swift India-US Bilateral Trade Agreement

Parliamentary Panel Pushes for Swift India-US Bilateral Trade Agreement

Rediff.com7 Aug 2026

A Parliamentary Standing Committee on Commerce has urged the Indian government to swiftly conclude the proposed India-US Bilateral Trade Agreement (BTA), while ensuring India's interests are protected, recommending complete exemption for key export products like generic medicines and smartphones from future US tariff increases.

Cipla Q1 net profit drops 39% to Rs 785.55 crore, North America sales down

Cipla Q1 net profit drops 39% to Rs 785.55 crore, North America sales down

Rediff.com23 Jul 2026

Homegrown pharma major Cipla Ltd reported a 39 per cent decline in consolidated net profit to Rs 785.55 crore in the first quarter ended June 2026, primarily due to a dip in sales in the North American market and higher expenses.

Why India Is Central To Rockwell Automation's Global Growth Plans

Why India Is Central To Rockwell Automation's Global Growth Plans

Rediff.com15 Jul 2026

Rockwell Automation's CEO Blake Moret highlights India as the centrepiece of the company's Asian growth strategy, detailing its four-decade presence, significant employee base, and support for the 'Make in India' initiative. The company sees major opportunities in pharmaceuticals, automotive, food and beverage, and consumer products, with AI playing a crucial role in simplifying industrial automation and boosting productivity for Indian manufacturers, including MSMEs.

'Mid- Small-Caps May Deliver More Selective Returns'

'Mid- Small-Caps May Deliver More Selective Returns'

Rediff.com28 Jul 2026

'The market is currently neither cheap enough to be exciting about nor expensive enough to worry about.'

Outbound M&A by Indian firms robust despite West Asia tensions: HSBC's Sharma

Outbound M&A by Indian firms robust despite West Asia tensions: HSBC's Sharma

Rediff.com10 Jul 2026

Indian companies' overseas expansion plans are holding strong despite geopolitical tensions in West Asia, driven by structural factors like supply-chain diversification, free trade agreements, and market expansion, according to Ajay Sharma, managing director and head of banking at HSBC India.

How BikeWo And Kwik Flite Are Revolutionising India's Logistics

How BikeWo And Kwik Flite Are Revolutionising India's Logistics

Rediff.com13 Jul 2026

BikeWo Green Tech and Kwik Flite Support have signed an initial pact to develop an integrated air cargo, aviation logistics, and multimodal freight platform. This collaboration aims to combine road mobility with aviation capabilities to serve various industries, focusing on high-value and time-sensitive logistics across India, including Tier-II and Tier-III cities.

Why FPI Selling Hasn't Hurt Markets

Why FPI Selling Hasn't Hurt Markets

Rediff.com13 Jul 2026

Foreign investors have largely been exiting one part of the market while domestic investors have been enthusiastically accumulating another, points out Debashis Basu.

Anupam Rasayan Pioneers ETFA Production With Innovative Chemistry Platform

Anupam Rasayan Pioneers ETFA Production With Innovative Chemistry Platform

Rediff.com12 Jun 2026

Specialty chemicals maker Anupam Rasayan India Ltd has become the first company globally to commercialise Ethyl trifluoroacetate (ETFA) production using its proprietary continuous flow chemistry platform. This innovative technology offers significant advantages over traditional methods, and ETFA is a crucial component for pharmaceuticals, life sciences, and performance materials, with a global market estimated at USD 500-600 million.

Indian Pharma Bets Beyond US Generics

Indian Pharma Bets Beyond US Generics

Rediff.com26 Jun 2026

Companies are investing heavily in complex injectables, respiratory therapies and biosimilars to improve margins and diversify portfolios.

Why Smallcaps Are Winning The Market Battle

Why Smallcaps Are Winning The Market Battle

Rediff.com26 Jun 2026

The remarkable rise of smallcaps reflects the emergence of a broad set of specialised businesses operating in industries where the sectoral tailwinds remain considerably stronger than macroeconomic headwinds, points out Debashis Basu.

Pharma distributor's licence cancelled over Kota C-section deaths

Pharma distributor's licence cancelled over Kota C-section deaths

Rediff.com26 Jun 2026

The World Health Organization has requested information from the Indian government regarding the alleged supply of spurious oxytocin injections linked to the deaths of five women in Kota hospitals. This comes after regulatory action, including the cancellation of manufacturing licenses for Jackson Laboratories units, following joint inspections by drug control bodies. The government is investigating the matter, emphasising a zero-tolerance approach to quality violations.

Novo Nordisk introduces 'Awiqli', a once-weekly insulin injection for diabetes in India

Novo Nordisk introduces 'Awiqli', a once-weekly insulin injection for diabetes in India

Rediff.com9 Jul 2026

Danish pharma major Novo Nordisk has launched 'Awiqli' in India, a once-weekly basal insulin injection for adults with diabetes, aiming to simplify treatment and reduce the burden of daily injections.

Jammu And Kashmir Police Bust Online Drug Supply Network, Seize 2,000 Pregabalin Capsules

Jammu And Kashmir Police Bust Online Drug Supply Network, Seize 2,000 Pregabalin Capsules

Rediff.com12 Jun 2026

Police in Doda district, Jammu and Kashmir, have busted an online drug supply network, seizing 2,000 pregabalin capsules. A suspect, Sarmad Ali Khan, was apprehended, and further investigation is underway to dismantle the syndicate.

Is Pharmaceutical Engg Better Than BPham And PharmD?

Is Pharmaceutical Engg Better Than BPham And PharmD?

Rediff.com11 Nov 2025

rediffGURU Nayagam PP advises young aspirants how to pick the right course and career.

Govt Clears Cancer Drug Price Hike

Govt Clears Cancer Drug Price Hike

Rediff.com11 Jun 2026

'While higher prices may create some financial burden for patients and caregivers in the short term, uninterrupted access to treatment remains the greater priority.'

Centre Tightens Rules on Alcohol-Based Medicines

Centre Tightens Rules on Alcohol-Based Medicines

Rediff.com11 Jul 2026

The move follows reports from several state drug-regulatory authorities indicating misuse and hoarding oral formulations with high ethyl-alcohol concentration, which people use as a substitute for liquor.

'Biotech Engineering Has Significant Potential'

'Biotech Engineering Has Significant Potential'

Rediff.com24 Jun 2026

rediffGURU Nayagam PP guides aspirants on how to pick the right career course and college based on their entrance scores and aptitude.

India's Exports Surge 18% in May, Trade Deficit Expands to $28.21 Billion

India's Exports Surge 18% in May, Trade Deficit Expands to $28.21 Billion

Rediff.com15 Jun 2026

India's exports reached a six-month high, growing by 18 per cent to USD 45.2 billion in May, driven by electronic goods, petroleum products, engineering items, and pharmaceuticals. However, the trade deficit widened to USD 28.21 billion due to a 10 per cent rise in imports, particularly petroleum products and gold, amidst surging crude oil prices.

Bharti Airtel Becomes India's Biggest Wealth Creator, IT Giants Lose 8.5 Trillion

Bharti Airtel Becomes India's Biggest Wealth Creator, IT Giants Lose 8.5 Trillion

Rediff.com3 Jul 2026

Bharti Airtel added 7.64 trillion in value over the past five years, making it the biggest wealth creator in India's private sector, while the IT sector, including TCS, Infosys, and Wipro, collectively lost 8.5 trillion in value, according to the latest Burgundy Private Hurun India 500 report.

India Inc to see 8.6-10.2% salary hikes in FY27, driven by skilled talent demand

India Inc to see 8.6-10.2% salary hikes in FY27, driven by skilled talent demand

Rediff.com9 Jun 2026

Corporate India is projected to offer salary increments ranging from 8.6 per cent to 10.2 per cent across various industries in the financial year 2026-27, primarily fuelled by a sustained demand for skilled and execution-focused talent, according to a TeamLease Services report.

Household Healthcare Costs Rise Again

Household Healthcare Costs Rise Again

Rediff.com4 Jun 2026

Private hospitals accounted for 30.8 per cent of current health expenditure in FY23, while pharmaceuticals and medical goods contributed more than 21 per cent, underlining continued dependence on private healthcare and medicine spending.

Rare Yellow Puffball Mushroom Discovery Highlights Arunachal Pradesh's Biodiversity

Rare Yellow Puffball Mushroom Discovery Highlights Arunachal Pradesh's Biodiversity

Rediff.com9 Jun 2026

A rare yellow puffball mushroom, provisionally identified as Bovista colorata, has been documented in Arunachal Pradesh's Longding district by the ICAR-Krishi Vigyan Kendra. This discovery highlights the state's rich biodiversity and the ecological importance of such fungi.

India-Oman Trade Pact: Unlocking Export Potential for Labour-Intensive Sectors

India-Oman Trade Pact: Unlocking Export Potential for Labour-Intensive Sectors

Rediff.com10 Jun 2026

The India-Oman free trade agreement, operationalised on June 1, is set to create significant export opportunities for India's labour-intensive and value-added sectors, including textiles, gems and jewellery, and marine products, while also strengthening energy security.

SETL Invests Rs 500 Crore In AI Datacenter Sector With GScale Energy Acquisition

SETL Invests Rs 500 Crore In AI Datacenter Sector With GScale Energy Acquisition

Rediff.com25 Jun 2026

Hyderabad-based SETL, a precision engineering company, has acquired a 51% majority stake in GScale Energy Private Limited, an AI Datacenter Engineering infrastructure specialist. This strategic move involves an initial investment of Rs 190 crore, with a total commitment of Rs 500 crore, marking SETL's expansion into the rapidly growing AI Datacenter sector and leveraging its expertise from pharmaceutical and chemical industries.

Modi-Takaichi Summit Opens New India-Japan Chapter

Modi-Takaichi Summit Opens New India-Japan Chapter

Rediff.com7 Jul 2026

Notwithstanding the economic complementarities and the host of agreements for deepening economic relation on a host of areas, both sides share common viewpoints on the foreign policy domain and seek common grounds to serve as a counterweight to China, notes Dr Rajaram Panda.

Why China's Bangladesh Push Should Worry India

Why China's Bangladesh Push Should Worry India

Rediff.com30 Jun 2026

Beijing clearly intends to extend the China-Myanmar Economic Corridor to Bangladesh as part of its larger Maritime Belt and Road Initiative to boost its Indian Ocean presence.

Indian Pharma Firms Deepen US Investment in Specialty Drugs Amidst Generic Pressure

Indian Pharma Firms Deepen US Investment in Specialty Drugs Amidst Generic Pressure

Rediff.com2 Jun 2026

Indian pharmaceutical companies are strategically increasing investments in the US market, focusing on specialty drugs, complex generics, respiratory products, and local manufacturing, despite a nearly 10 per cent fall in exports to the US in FY26 due to pricing pressure and competition in traditional generics.

Large Codeine Cough Syrup Consignment Seized In Uttar Pradesh

Large Codeine Cough Syrup Consignment Seized In Uttar Pradesh

Rediff.com31 May 2026

Authorities in Uttar Pradesh's Gonda district have seized a large consignment of codeine-based cough syrup, prompting an investigation into its procurement and intended distribution. The seizure led to a halt in sales as officials examine records and supply chain details to verify the legality of the transaction.

India, Venezuela vow long-term energy tie-up

India, Venezuela vow long-term energy tie-up

Rediff.com4 Jun 2026

India's procurement of Venezuelan crude oil has picked up momentum since April and the South American nation has already emerged as the third largest oil supplier to the country.